Literature DB >> 6129425

Coeliac disease and malignancy.

C M Swinson, G Slavin, E C Coles, C C Booth.   

Abstract

Patients with coeliac disease are at greater risk than the general population for the development of malignant neoplasms, particularly lymphomas. Of 259 histologically confirmed malignancies in 235 patients with histologically proven coeliac disease, 133 were malignant lymphomas, the predominant histological type being malignant histiocytosis and the commonest site of this lesion the small intestine. Patients with coeliac disease also have a greatly increased risk for the development of small-intestinal adenocarcinomas. Among 116 invasive non-lymphomatous malignancies there were 19 small-intestinal adenocarcinomas, compared with 0 . 23 expected from national cancer registrations adjusted for sex and age. There were also more oesophageal and pharyngeal squamous carcinomas than expected.

Entities:  

Mesh:

Year:  1983        PMID: 6129425     DOI: 10.1016/s0140-6736(83)91754-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

1.  Celiac sprue among US military veterans: associated disorders and clinical manifestations.

Authors:  F Delcò; H B El-Serag; A Sonnenberg
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Coeliac disease and disseminated lymphomatosis.

Authors:  M K Kulshrestha; W P Honan; N Aluwihare; M Carey; R N Allan
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

3.  Enteropathy-associated T-cell lymphoma involving the colon and extraintestinal B-cell lymphoma in celiac disease.

Authors:  Shyam Varadarajulu; David Lewin
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 4.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

5.  Mortality and causes of death in celiac disease in a Mediterranean area.

Authors:  M Cottone; A Termini; L Oliva; A Magliocco; C Marrone; A Orlando; F Pinzone; R Di Mitri; M Rosselli; A Rizzo; L Pagliaro
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

6.  Screening for celiac disease in average-risk and high-risk populations.

Authors:  Saurabh Aggarwal; Benjamin Lebwohl; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

7.  Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing.

Authors:  G Barera; C Bianchi; L Calisti; F Cerutti; F Dammacco; E Frezza; M T Illeni; L Mistura; M Pocecco; F Prisco
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

8.  Malignancy in coeliac disease--effect of a gluten free diet.

Authors:  G K Holmes; P Prior; M R Lane; D Pope; R N Allan
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

9.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.

Authors:  A Al-Toma; W H M Verbeek; M Hadithi; B M E von Blomberg; C J J Mulder
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

10.  Risk factors for small intestine cancer.

Authors:  W H Chow; M S Linet; J K McLaughlin; A W Hsing; H T Chien; W J Blot
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.